Abbott India, Apollo Hospitals to co-create cardiac registry
- by Team ABLE - 17 Jun, 2019
Apollo Hospitals and healthcare firm Abbott have come together to create a cardiac registry. This, according to the firms is an effort to identify heart-related risk factors for the Indian population. The two companies will collect heart health data of Apollo patients including troponin levels measured using Abbott’s blood test. The data will be used to map risk factors so patients could be alerted to make lifestyle changes and avert incidents such as a heart attack.It is claimed that Apollo has been the first hospital to have adopted this technology.
Explaining the need to have India-specific risk factors and interventions,Dr K Hari Prasad, President, Hospitals Division, Apollo Hospitals, said, “Indians are getting heart diseases between 45 and 50 years of age, much earlier than their Western counterparts who have such incidents at about 60 years of age.”
Late last year, Abbott’s High Sensitive Troponin-I blood test received regulatory approvals in Europe for being able to accurately predict the chances of having a heart attack or a cardiac event, potentially months to years in advance in people who otherwise appear healthy. The protein Troponin I is released when the heart muscles are stressed, and in the past, similar products have been used in emergency situations or in ICUs when a patient showed symptoms of a heart attack.Abbott’s high-sensitive product has received approvals for a new indication where it picks up heart-attack signals in a seemingly healthy person.
Apollo and Abbott will screen patients at Apollo and the data will be held in a registry that Dr Prasad hopes would expand to capturing data from more cardiac patients and hospitals in the long run.The absence of a patient registry is often felt in the country, especially when there is an adverse event or recall involving a medical product, and doctors need to contact a patient to address the medical issue.
The two companies will collect heart health data of Apollo patients including troponin levels measured using Abbott’s blood test.